Results 1 to 10 of about 2,541 (178)

Assessment and predictive analysis of health professions students' proficiency in health economics and pharmacoeconomics in Southwest China: a cross-sectional study [PDF]

open access: yesBMC Medical Education
Objectives This study addresses the growing importance of health economics and pharmacoeconomics in preparing healthcare professionals for economic decision-making, particularly in China’s evolving healthcare system.
Jian Yang   +5 more
doaj   +3 more sources

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Lower income European countries (LIECs) have more limited financial resources to cover high‐cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by transferring real‐world evidence (RWE ...
Kaló Z   +25 more
europepmc   +2 more sources

Disease and Economic Burden Averted by Hib Vaccination in 160 Countries: A Machine-Learning Analysis [PDF]

open access: yesVaccines
Background: Global immunization against Haemophilus influenzae type b (Hib) has expanded with Gavi support. We estimated health, economic benefits, equity and cost-effectiveness in 159 countries (1990–2021), and projected effects of future introduction ...
Dachuang Zhou   +9 more
doaj   +2 more sources

The online purchase of medicines – an international pharmacists’ perspective [PDF]

open access: yesFrontiers in Pharmacology
BackgroundAccessibility and affordability of medicines are key for patients’ effective treatment. However, drug prices are soaring, and patients are looking for cheaper medications in Europe and beyond.
Tomasz Zaprutko   +12 more
doaj   +2 more sources

A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China. [PDF]

open access: yesHealth Expect
ABSTRACT Objective To develop a multi‐stakeholder, consensus‐based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. Methods A two‐round Delphi survey was conducted with a multidisciplinary expert panel (n = 62 in Round 1; n =
Zhao J   +16 more
europepmc   +2 more sources

Cost-Variation Analysis of Antihemorrhagic Drugs in the Egyptian Market

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2023
Background: Cardiovascular diseases (CVDs) are considered the leading cause of death worldwide. An important category of the CVDs is the bleeding disorders.
Michael A. Kaldas   +2 more
doaj   +1 more source

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation

open access: yesFrontiers in Public Health, 2021
Background: Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice, which brings great economic burden to patients. This study evaluated the economics of the new antiarrhythmic drug dronedarone and provides suggestions for ...
Mengran Zhang   +8 more
doaj   +1 more source

Research on the State of Awareness of Pharmaceutical Workers About Coronavirus Disease (COVID-19)

open access: yesFamily medicine. European practices, 2022
The article presents the results of a survey of 269 pharmaceutical workers to determine the level of knowledge of the etiology, pathogenesis, treatment and prevention of coronavirus disease (COVID-19) in order to provide complete and quality ...
O. Semenov, O. Zaliska
semanticscholar   +1 more source

The Increasing role of health economics in the HTA of COVID19-vaccines

open access: yesMacedonian Pharmaceutical Bulletin, 2022
1 Department of Health Sciences, University of Groningen, University Medical Center Groningen, The Netherlands 2 Pharmacoeconomics Advice Groningen, Groningen, The Netherlands 3 Health-Ecore Ltd., Zeist, The Netherlands 4 Unit of PharmacoTherapy ...
M. J. Postma, T. Fens, C. Boersma
semanticscholar   +1 more source

Economic Burden of Myocardial Infarction Combined With Dyslipidemia

open access: yesFrontiers in Public Health, 2021
Background: Dyslipidemia is a common comorbidity and an important risk factor for myocardial infarction (MI). This study aimed to examine the economic burden of MI combined with dyslipidemia in China.Methods: Patients who were hospitalized due to MI ...
Pingyu Chen   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy